Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2077-2092
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2077
Table 1 Description of cholangiocarcinoma patients diagnosed between 2014 and 2017 in England, and subgroup who did not receive surgery up to 12 mo after diagnosis
Characteristics
Total
Did not receive surgery
Total patients (n, %)8853 (100.0)7751 (100.0)
Age at diagnosis (yr)
    0-44180 (2.0)117 (1.5)
    45-54442 (5.0)320 (4.1)
    55-641231 (13.9)962 (12.4)
    65-742407 (27.2)1963 (25.3)
    75-842814 (31.8)2615 (33.7)
    > 841779 (20.1)1774 (22.9)
Gender
    Male4343 (49.1)3721 (48.0)
    Female4510 (50.9)4030 (52.0)
Year of diagnosis
    20142055 (23.2)1802 (23.2)
    20152213 (25.0)1951 (25.2)
    20162259 (25.5)1983 (25.6)
    20172326 (26.3)2015 (26.0)
Route to diagnosis
    Emergency presentation4276 (48.3)3975 (51.3)
    TWW referral1490 (16.8)1306 (16.8)
    Other GP referral1844 (20.8)1500 (19.4)
    Other979 (11.1)729 (9.4)
    Unknown264 (3.0)241 (3.1)
Stage at diagnosis
    1310 (3.5)203 (2.6)
    2686 (7.7)283 (3.7)
    3330 (3.7)26 (2.9)
    43506 (39.6)3213 (41.5)
    Missing4021 (45.4)3826 (49.4)
Tumour sub-type
    CCA Other391 (4.4)378 (4.9)
    eCCA1595 (18.0)1200 (15.5)
    iCCA6867 (77.6)6173 (79.6)
Tumour morphology
    Adenomas and adenocarcinomas8570 (96.8)7484 (96.6)
    Other283 (3.2)267 (3.4)
English Index of Multiple Deprivation, income component
    Quintile 1 (least deprived)1715 (19.4)1466 (18.9)
    Quintile 21863 (21.0)1609 (20.8)
    Quintile 31797 (20.3)1589 (20.5)
    Quintile 41806 (20.4)1590 (20.5)
    Quintile 5 (most deprived)1672 (18.9)1497 (19.3)
Charlson comorbidity index
    06220 (70.3)5340 (68.9)
    11140 (12.9)1025 (13.2)
    2678 (7.7)623 (8.0)
    3+815 (9.2)763 (9.8)
Underlying liver disease
    No8044 (90.9)7101 (91.6)
    Yes809 (9.1)650 (8.4)
Cancer Alliance at diagnosis
    Cheshire and Merseyside427 (4.8)358 (4.6)
    East Midlands795 (9.0)703 (9.1)
    East of England-North524 (5.9)478 (6.2)
    East of England-South558 (6.3)476 (6.1)
    Greater Manchester521 (5.9)453 (5.8)
    Humber, Coast and Vale310 (3.5)269 (3.5)
    Kent and Medway251 (2.8)226 (2.9)
    Lancashire and South Cumbria330 (3.7)285 (3.7)
    North Central London141 (1.6)119 (1.5)
    North East London173 (2.0)150 (1.9)
    North West and South West London358 (4.0)302 (3.9)
    Northern715 (8.1)628 (8.1)
    Peninsula362 (4.1)311 (4.0)
    Somerset, Wiltshire, Avon and Gloucestershire417 (4.7)374 (4.8)
    South East London163 (1.8)141 (1.8)
    South Yorkshire and Bassetlaw229 (2.6)201 (2.6)
    Surrey and Sussex488 (5.5)442 (5.7)
    Thames Valley234 (2.6)202 (2.6)
    Wessex475 (5.4)419 (5.4)
    West Midlands1013 (11.4)883 (11.4)
    West Yorkshire and Harrogate369 (4.2)331 (4.3)
Treatment received
Surgery only507 (5.7)0 (0.0)
Surgery + systemic therapy367 (4.1)0 (0.0)
Surgery + stent insertion118 (1.3)0 (0.0)
Surgery + systemic therapy + stent insertion110 (1.2)0 (0.0)
Systemic therapy only1127 (12.7)1127 (14.5)
Stent insertion only1741 (19.7)1741 (22.5)
Systemic therapy + stent insertion415 (4.7)415 (5.4)
None of surgery, systemic therapy or stent insertion4468 (50.5)4468 (57.6)
Table 2 Estimated percentage of cholangiocarcinoma patients in England 2014-2017 that received
A: Potentially curative surgery
B: Systemic therapy in those who did not receive surgery
C: Stent insertion in those who did not receive surgery
Unadjusted
Adjusted
Unadjusted
Adjusted
Unadjusted
Adjusted
Estimate (95%CI)
Estimate 95%CI
Estimate (95%CI)
Estimate 95%CI
Estimate (95%CI)
Estimate 95%CI
Population average (intercept)12.45(11.76, 13.14)12.45(11.81, 13.09)19.89(19.01, 20.78)19.89(19.1, 20.69)27.82(26.85, 28.78)27.82(26.85, 28.78)
Cheshire and Merseyside3.71(0.32, 7.10)3.77(0.54, 6.99)-1.18(-5.13, 2.78)-0.09(-3.88, 3.70)2.35(-2.29, 6.99)3.50(-1.15, 8.16)
East Midlands-0.88(-3.00, 1.25)-1.11(-3.10, 0.87)-0.12(-2.93, 2.69)-0.60(-3.14, 1.93)-1.93(-5.02, 1.16)-2.43(-5.45, 0.60)
East of England - North-3.67(-6.05, -1.29)-3.96(-6.34, -1.59)0.82(-2.70, 4.34)-0.06(-3.17, 3.04)13.40(9.15, 17.65)11.59(7.44, 15.74)
East of England - South2.25(-0.59, 5.08)1.33(-1.36, 4.01)-1.62(-4.99, 1.76)-2.70(-5.68, 0.29)9.79(5.59, 13.98)10.26(6.14, 14.38)
Greater Manchester0.60(-2.20, 3.41)-1.32(-3.93, 1.29)-0.03(-3.59, 3.54)0.86(-2.38, 4.09)0.88(-3.16, 4.92)-2.48(-6.37, 1.40)
Humber, Coast and Vale0.78(-2.93, 4.49)2.14(-1.29, 5.58)-0.56(-5.21, 4.09)0.78(-3.33, 4.88)-10.72(-15.18, -6.25)-10.32(-14.62, -6.03)
Kent and Medway-2.49(-6.16, 1.19)-2.14(-5.75, 1.47)-0.87(-5.93, 4.19)-0.77(-5.43, 3.88)3.60(-2.38, 9.58)4.51(-1.43, 10.44)
Lancashire and South Cumbria1.19(-2.45, 4.82)1.63(-1.72, 4.98)2.21(-2.52, 6.94)2.43(-1.74, 6.60)1.66(-3.54, 6.86)3.18(-1.90, 8.25)
North Central London3.16(-2.84, 9.15)2.36(-3.22, 7.94)9.52(1.30, 17.73)9.28(1.76, 16.80)3.28(-5.08, 11.63)3.18(-4.95, 11.32)
North East London0.85(-4.19, 5.89)-0.05(-4.79, 4.69)6.77(-0.28, 13.82)5.93(-0.41, 12.26)9.52(1.80, 17.23)10.48(2.89, 18.06)
North West and South West London3.19(-0.48, 6.87)2.68(-0.79, 6.15)7.26(2.35, 12.17)6.23(2.02, 10.43)-3.97(-8.70, 0.75)-3.16(-7.84, 1.53)
Northern-0.28(-2.58, 2.02)-0.10(-2.20, 2.00)2.40(-0.71, 5.51)2.52(-0.35, 5.40)-9.82(-12.74, -6.90)-9.63(-12.58, -6.69)
Peninsula1.64(-1.87, 5.15)1.72(-1.43, 4.87)-1.24(-5.50, 3.01)-0.01(-3.76, 3.75)5.95(0.80, 11.09)6.65(1.64, 11.66)
Somerset, Wiltshire, Avon and Gloucestershire-2.14(-5.00, 0.73)-1.37(-4.02, 1.29)-2.51(-6.28, 1.25)-1.97(-5.34, 1.41)8.82(4.07, 13.57)8.87(4.14, 13.59)
South East London1.05(-4.19, 6.28)2.51(-2.6, 7.62)2.09(-4.74, 8.92)3.20(-2.82, 9.23)-2.28(-9.48, 4.91)-2.08(-9.08, 4.91)
South Yorkshire and Bassetlaw-0.22(-4.43, 3.98)1.66(-2.28, 5.59)-7.46(-12.01, -2.91)-3.84(-8.04, 0.35)-1.45(-7.49, 4.59)-3.75(-9.79, 2.29)
Surrey and Sussex-3.02(-5.56, -0.48)-3.79(-6.27, -1.30)1.37(-2.33, 5.07)-0.76(-4.14, 2.61)13.59(9.15, 18.02)13.64(9.22, 18.06)
Thames ValleyA1.23(-3.13, 5.58)0.07(-3.96, 4.10)4.36(-1.49, 10.21)2.00(-3.52, 7.52)-9.50(-14.81, -4.19)-8.26(-13.63, -2.89)
Wessex-0.66(-3.49, 2.17)-0.36(-2.99, 2.27)-0.32(-4.02, 3.38)-1.55(-4.89, 1.80)-1.09(-5.21, 3.04)-0.29(-4.30, 3.72)
West Midlands0.39(-1.55, 2.32)1.48(-0.33, 3.29)-4.49(-6.77, -2.22)-3.31(-5.39, -1.24)-11.73(-14.08, -9.39)-10.54(-12.88, -8.20)
West Yorkshire and Harrogate-2.15(-5.20, 0.90)-2.47(-5.40, 0.46)-0.26(-4.45, 3.94)-0.71(-4.35, 2.92)-4.86(-9.31, -0.40)-6.69(-10.88, -2.50)
Age 0-4422.14(15.21, 29.08)20.69(13.91, 27.47)37.29(28.28, 46.31)36.41(27.47, 45.35)-1.37(-9.44, 6.70)-1.59(-9.41, 6.24)
Age 45-5415.07(11.03, 19.11)13.24(9.38, 17.11)30.34(24.98, 35.70)28.96(23.77, 34.15)-4.91(-9.47, -0.34)-5.80(-10.26, -1.34)
Age 55-649.38(7.31, 11.46)7.59(5.58, 9.61)23.18(20.34, 26.03)21.61(18.82, 24.40)-0.07(-2.73, 2.59)-0.39(-3.00, 2.21)
Age 65-746.11(4.86, 7.36)4.84(3.64, 6.04)10.60(8.94, 12.26)9.59(7.97, 11.21)1.47(-0.27, 3.21)1.75(0.06, 3.44)
Age 75-84-5.41(-6.29, -4.53)-4.83(-5.69, -3.96)-8.88(-9.95, -7.81)-8.68(-9.73, -7.63)1.49(0.07, 2.90)1.53(0.16, 2.90)
Age 85+-12.21(-12.9, -11.52)-9.55(-10.28, -8.83)-19.18(-20.05, -18.30)-17.16(-18.08, -16.23)-2.81(-4.6, -1.01)-2.83(-4.64, -1.02)
Female-1.81(-2.49, -1.13)-0.49(-1.13, 0.16)-0.30(-1.16, 0.56)1.21(0.43, 2.00)-1.09(-2.05, -0.12)-1.18(-2.13, -0.24)
Male1.88(1.17, 2.58)0.51(-0.16, 1.18)0.33(-0.60, 1.26)-1.32(-2.16, -0.47)1.18(0.13, 2.22)1.28(0.25, 2.31)
Income deprivation quintile 1 (least deprived)2.12(0.63, 3.61)2.04(0.64, 3.43)3.15(1.22, 5.08)3.17(1.41, 4.92)0.98(-1.11, 3.08)0.47(-1.59, 2.52)
Income deprivation quintile 21.23(-0.15, 2.61)1.17(-0.11, 2.45)1.44(-0.34, 3.22)1.88(0.29, 3.47)1.07(-0.91, 3.04)0.30(-1.60, 2.20)
Income deprivation quintile 3-0.90(-2.24, 0.43)-0.21(-1.47, 1.05)-0.21(-1.96, 1.54)0.24(-1.32, 1.79)1.14(-0.85, 3.13)0.66(-1.26, 2.59)
Income deprivation quintile 4-0.50(-1.84, 0.85)-0.38(-1.63, 0.88)-2.53(-4.23, -0.84)-2.32(-3.85, -0.79)-0.98(-2.93, 0.98)-1.08(-2.98, 0.82)
Income deprivation quintile 5 (most deprived)-2.03(-3.38, -0.68)-2.77(-4.10, -1.43)-1.70(-3.48, 0.07)-2.91(-4.59, -1.22)-2.28(-4.28, -0.27)-0.34(-2.33, 1.65)
Diagnosis year 2014-0.16(-1.41, 1.08)0.49(-0.67, 1.65)-1.46(-3.05, 0.12)0.08(-1.35, 1.50)-1.85(-3.64, -0.06)-1.81(-3.53, -0.09)
Diagnosis year 2015-0.64(-1.81, 0.54)-0.48(-1.57, 0.61)-0.77(-2.29, 0.75)-0.56(-1.93, 0.81)-0.55(-2.27, 1.16)-0.29(-1.95, 1.36)
Diagnosis year 2016-0.24(-1.42, 0.93)-0.30(-1.41, 0.80)0.69(-0.85, 2.22)0.08(-1.29, 1.46)0.82(-0.90, 2.53)1.04(-0.62, 2.69)
Diagnosis year 20171.00(-0.19, 2.20)0.32(-0.79, 1.43)1.41(-0.14, 2.95)0.39(-0.99, 1.77)1.42(-0.31, 3.14)0.88(-0.77, 2.53)
Adenomas and adenocarcinomas0.23(0.14, 0.32)0.24(0.14, 0.35)0.49(0.38, 0.59)0.23(0.10, 0.36)-0.04(-0.23, 0.15)0.40(0.18, 0.61)
Other morphology-6.82(-9.54, -4.10)-7.35(-10.55, -4.16)-13.58(-16.57, -10.59)-6.38(-10.05, -2.72)1.08(-4.31, 6.48)-11.15(-17.12, -5.18)
eCCA sub-type12.40(10.56, 14.23)12.34(10.58, 14.10)1.64(-0.50, 3.78)2.89(0.92, 4.87)19.07(16.51, 21.62)19.28(16.7, 21.86)
iCCA sub-type-2.35(-2.78, -1.93)-2.65(-3.09, -2.22)0.10(-0.35, 0.55)-0.47(-0.92, -0.02)-3.66(-4.20, -3.13)-3.89(-4.47, -3.31)
Other sub-type-9.17(-11.00, -7.33)-3.70(-6.01, -1.38)-6.74(-10.12, -3.36)-1.52(-4.98, 1.94)-0.62(-5.01, 3.78)2.37(-2.50, 7.24)
Emergency presentation diagnosis route-5.45(-6.14, -4.76)-3.75(-4.42, -3.08)-7.95(-8.80, -7.09)-5.31(-6.11, -4.51)1.52(0.55, 2.49)2.10(1.14, 3.07)
GP referral diagnosis route6.16(4.65, 7.68)4.61(3.17, 6.05)6.10(4.15, 8.04)4.18(2.39, 5.97)-4.60(-6.54, -2.65)-5.28(-7.16, -3.40)
IP and OP diagnosis route13.04(10.54, 15.55)9.44(7.09, 11.79)12.54(9.35, 15.73)7.65(4.69, 10.61)-2.76(-5.77, 0.25)-2.75(-5.69, 0.18)
TWW referral diagnosis route-0.14(-1.66, 1.37)-0.58(-2.08, 0.91)10.96(8.75, 13.18)8.57(6.55, 10.59)2.92(0.65, 5.19)2.29(0.06, 4.51)
Unknown diagnosis route-2.99(-7.06, 1.07)-3.21(-6.51, 0.08)-5.61(-10.73, -0.49)-8.05(-11.96, -4.15)-5.21(-11.31, 0.89)-5.94(-11.07, -0.81)
Charlson score - 01.69(1.28, 2.10)0.69(0.30, 1.09)3.19(2.65, 3.73)1.02(0.51, 1.53)1.52(0.86, 2.18)1.38(0.73, 2.04)
Charlson score - 1-2.31(-3.98, -0.64)-0.28(-1.85, 1.29)-3.40(-5.56, -1.25)0.42(-1.52, 2.37)-1.73(-4.26, 0.80)-2.00(-4.45, 0.45)
Charlson score - 2-4.32(-6.35, -2.29)-2.06(-3.96, -0.17)-6.06(-8.71, -3.40)-0.81(-3.25, 1.63)-1.97(-5.30, 1.35)-1.77(-4.94, 1.40)
Charlson score - 3+-6.07(-7.74, -4.39)-3.19(-4.79, -1.60)-12.84(-14.71, -10.97)-7.06(-8.93, -5.20)-6.73(-9.52, -3.93)-5.53(-8.33, -2.74)
Liver disease-no-0.73(-0.99, -0.47)-0.35(-0.60, -0.10)-0.51(-0.80, -0.21)0.04(-0.25, 0.32)0.46(0.17, 0.75)0.38(0.10, 0.67)
Liver disease-yes7.23(4.65, 9.82)3.47(0.96, 5.97)5.53(2.33, 8.73)-0.43(-3.55, 2.69)-4.99(-8.11, -1.86)-4.19(-7.29, -1.08)